Vaccine options for influenza: thinking small.

Area of Science:

• Virology
• Immunology
• Vaccine Development

Background:

• Influenza viruses pose a significant global health threat.
• Broadly protective vaccines targeting conserved viral epitopes are needed.
• Current vaccines primarily target variable regions, limiting broad protection.

Purpose of the Study:

• To evaluate the matrix protein 2 ectodomain (M2e) as a universal influenza A vaccine candidate.
• To assess the safety, immunogenicity, and protective efficacy of M2e-based vaccines.
• To explore the mechanism of protection conferred by M2e-specific antibodies.

Main Methods:

• Focus on the M2e antigen for vaccine design.
• Expression and delivery of M2e in various formats.
• Testing M2e-based vaccines in experimental influenza A virus challenge models.
• Clinical studies to assess safety and immunogenicity.

Main Results:

• M2e is a suitable candidate due to its small size and high solubility.
• M2e-based vaccines demonstrated protection against influenza A virus challenge in natural hosts.
• Clinical studies confirmed the safety and immunogenicity of M2e vaccines.
• M2e-specific antibodies mediate protection via Fc receptor-mediated phagocytosis.

Conclusions:

• M2e-based vaccines represent a promising strategy for universal influenza A protection.
• The mechanism of M2e antibody protection is similar to hemagglutinin stalk antibodies.
• A combination of conserved antigens, including M2e, is likely necessary for effective influenza vaccines.